Full Name
Hagen, T.
Hagen, Thilo
Main Affiliation


Results 1-13 of 13 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
12016C. elegans miro-1 mutation reduces the amount of mitochondria and extends life spanShen Y. ; Ng L.F. ; Low N.P.W.; Hagen T. ; Gruber J. ; Inoue T. 
22018Characterisation of cellular effects of Burkholderia pseudomallei cycle inhibiting factor (Cif)Ng M.Y. ; Gan Y.-H. ; Hagen T. 
32009Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3βHagen, T. 
42011Compound C prevents Hypoxia-Inducible Factor-1 protein stabilization by regulating the cellular oxygen availability via interaction with Mitochondrial Complex iChua Y.L.; Hagen T. 
52010Heteroaromatic 4-arylquinols are novel inducers of Nuclear factor-erythroid 2-related factor 2 (Nrf2)Wong, D.P.W.; Hagen, T. ; Wells, G.
69-Sep-2014Investigating the molecular basis of Siah1 and Siah2 E3 ubiquitin ligase substrate specificityGopalsamy, Anupriya; Hagen, Thilo ; Swaminathan, Kunchithapadam 
72012Mechanism of cullin3 E3 ubiquitin ligase dimerizationChoo Y.Y.; Hagen T. 
82013mTORC1 Dependent Regulation of REDD1 Protein StabilityTan C.Y. ; Hagen T. 
92011Regulation of cullin ring e3 ubiquitin ligases by cand1 in vivoChua Y.S.; Boh B.K.; Ponyeam W.; Hagen T. 
102010Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activityChua, Y.S.; Chua, Y.L.; Hagen, T. 
112009Structure-activity analysis of 2′-modified cinnamaldehyde analogues as potential anticancer agentsGan, F.F. ; Chua, Y.S.; Hagen, T. ; Scarmagnani, S.; Palaniappan, P.; Westwell, A.D.; Franks, M.; Bradshaw, T.D.; Poobalasingam, T.
122016The role of mitochondrial non-enzymatic protein acylation in ageingHong S.Y.; Ng L.T.; Ng L.F.; Inoue T.; Tolwinski N.S. ; Hagen T. ; Gruber J. 
132012The role of the cullin-5 E3 ubiquitin ligase in the regulation of insulin receptor substrate-1Hu C.Z. ; Sethi J.K.; Hagen T.